These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3096830)

  • 1. Myelofibrosis: a role for platelet derived growth factor (PDGF)?
    Romano M; Poggi A
    Haematologica; 1986; 71(5):359-61. PubMed ID: 3096830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of PDGF on myeloproliferative disorders].
    Kimura A; Katoh O; Kuramoto A
    Rinsho Ketsueki; 1988 Jul; 29(7):989-93. PubMed ID: 3184485
    [No Abstract]   [Full Text] [Related]  

  • 3. Case of myelofibrosis with hypertrophic osteoarthropathy: the role of platelet-derived growth factor in pathogenesis.
    John B; Subhash H; Thomas K
    N Z Med J; 2004 Apr; 117(1192):U853. PubMed ID: 15107873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Does platelet derived growth factor induce myelofibrosis in agnogenic myeloid metaplasia?].
    Teplizky H; Dvilansky A
    Harefuah; 1987 Jan; 112(2):102-4. PubMed ID: 3596376
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.
    Bock O; Loch G; Büsche G; von Wasielewski R; Schlué J; Kreipe H
    Haematologica; 2005 Jan; 90(1):133-4. PubMed ID: 15642683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
    Castro-Malaspina H; Moore MA
    Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
    Yonekura S
    Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
    [No Abstract]   [Full Text] [Related]  

  • 9. Megakaryocytes and myelofibrosis in gray platelet syndrome.
    Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
    Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet-derived growth factor: mechanism of action and role in the development of diseases].
    Almazov VA; Blagosklonnyĭ MV; Zaritskiĭ AIu
    Ter Arkh; 1984; 56(7):144-7. PubMed ID: 6385321
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
    Castro-Malaspina H
    Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of growth factors of platelets (PDGF, TGF-beta, EGF) in the pathogenesis of myelofibrosis].
    Kimura A; Katoh O; Kuramoto A
    Rinsho Byori; 1989 Apr; Spec No 81():1-8. PubMed ID: 2787864
    [No Abstract]   [Full Text] [Related]  

  • 14. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of myelofibrosis in myeloproliferative disorders.
    Groopman JE
    Ann Intern Med; 1980 Jun; 92(6):857-8. PubMed ID: 7387029
    [No Abstract]   [Full Text] [Related]  

  • 17. On the pathogenesis of angiogenesis in idiopathic myelofibrosis.
    Hasselbalch H
    Am J Hematol; 1990 Feb; 33(2):151. PubMed ID: 1689101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic and clinical study of platelet-derived growth factor gene expression].
    Takimoto Y; Kimura A
    Rinsho Ketsueki; 1994 Apr; 35(4):364-9. PubMed ID: 8028181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of PL-derived growth factor on osteogenesis and skeletal reconstruction].
    Luo QF; Wang X
    Shanghai Kou Qiang Yi Xue; 2004 Jun; 13(3):207-10. PubMed ID: 15269861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spleen versus bone marrow in idiopathic myeloid metaplasia].
    Aggio MC
    Sangre (Barc); 1984; 29(3):294-8. PubMed ID: 6207598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.